Clinical Trial: PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL

U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07829445) titled 'PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL' on Sept. 17.

Brief Summary: To determine whether special laboratory tests, called genomic sequencing, can identify specific subtypes of LBCL and provide information that may help guide treatment decisions.

Study Start Date: Feb. 25, 2027

Study Type: OBSERVATIONAL

Condition: LBCL Comprehensive Genomic Precision Treatment

Intervention: OTHER: Standard of Care (SOC)

Standard of care

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services with permission from Healt...